Cesar A. De Las Casas, MD, MPH, GRACE Faculty

Twitter Feed
Oncologist
Memorial Cancer Institute
Miami
FL
Specialties
Hematology and Oncology

Cesar A. De Las Casas, MD, MPH, board-certified hematologist and oncologist. He earned his medical degree from the Universidad Peruana Cayetano Heredia in Lima in 1994. He completed his internship in internal medicine at the Baylor College of Medicine in 1999, serving as Chief Medical Resident at St. Luke’s Episcopal Hospital in Houston and at Ben Taub Hospital in 1999 and 2000.

Conflict of Interest

None

GRACE sat down with Cesar A. De Las Casas, MD, MPH, to discuss information regarding if there a preferred induction therapy (¿¿Hay alguna terapia de inducción preferida?). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Multiple Myeloma, (Mieloma Múltiple).


Transcription:

¿Hay alguna terapia de inducción preferida?

GRACE sat down with Cesar A. De Las Casas, MD, MPH, to discuss information regarding the new antibodies for multiple myeloma (MM) therapy (¿Cuáles son los anticuerpos nuevos para la terapia del mieloma múltiple (MM)?). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Multiple Myeloma, (Mieloma Múltiple). 


 

We would like to thank the following company for their support of this program:

 

GRACE sat down with Cesar A. De Las Casas, MD, MPH, to discuss information regarding whether all patients should receive an autologous transplant (¿Todos deberían de recibir un trasplante autólogo?). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Multiple Myeloma, (Mieloma Múltiple).


 

We would like to thank the following company for their support of this program:

GRACE sat down with Cesar A. De Las Casas, MD, MPH, to discuss information regarding if there is a best maintenance therapy (¿Existe una terapia de mantenimiento mejor sobre las demás?). Stay tuned for more on our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments, and Multiple Myeloma, (Mieloma Múltiple).


 

We would like to thank the following company for their support of this program:

Forum Discussions

Original post date:

Join us now at https://us02web.zoom.us/s/82170808361

the Q&A begins 11:25 ET!

Last Activity: Sat, 08/12/2023 - 07:47
Original post date:

Hi there -- 

Image
montalcino

I am Denise Brock - the Operations Director for GRACE, the Global Resource for Advancing Cancer Education.  I began working with Jack West in 2009, 1 year after my best friend was

Last Activity: Tue, 07/18/2023 - 14:24
Original post date:

There is not a ton of info available for Cholangiocarcinoma, so seeing information come up with new developments is always exciting.  In this video, Rachna Shroff MD, chief of Gastrointestinal Medical

Last Activity: Thu, 10/13/2022 - 17:04
Original post date:

Hi all -- share your cancer journey here and connect with others.  Cancer.gov has a good general description of Cholangiocarcinoma.  This rare disease has support information and programs that can be

Last Activity: Mon, 02/21/2022 - 11:15
Original post date:

Keep your eye out for new Head and Neck information soon! 

Last Activity: Sat, 02/05/2022 - 12:12

Comments

Post Date:
Original Post: Three Year Post Update

Hi Stan!  It is good to hear from you -- I am so very happy you are doing well.  I agree with Janine

Post Date:
Original Post: Two Years After....

Stan - Thank you once again for your kind words.  Thank you as well for your donation.  As you know

Post Date:
Original Post: Jim's caregiver story

I had a very wonderful conversation with a fantastic person, Tom Murphy, after he had started Barb's

Post Date:
Original Post: Denise's Story

Janine -- I know how my world felt, but how is your world different?  - thankfully your husband is

Post Date:

Thank you Janine for mentioning the program!  I wanted to make the point that this program offers a